0001193125-20-050063.txt : 20200226 0001193125-20-050063.hdr.sgml : 20200226 20200226160552 ACCESSION NUMBER: 0001193125-20-050063 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200224 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 20655668 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FIVE PRIME THERAPEUTICS INC DATE OF NAME CHANGE: 20020613 8-K 1 d892673d8k.htm 8-K 8-K
false 0001175505 0001175505 2020-02-24 2020-02-24

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 24, 2020.

 

Five Prime Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

  

001-36070

  

26-0038620

(state or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

111 Oyster Point Boulevard

South San Francisco, California

  

94080

(Address of principal executive offices)

  

(Zip Code)

Registrant’s telephone number, including area code: (415) 365-5600

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

  

Trading

Symbol(s)

  

Name of Each Exchange

on Which Registered

Common Stock, par value $0.001 per share

  

FPRX

  

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 24, 2020, the Compensation and Management Development Committee of the Board of Directors of Five Prime Therapeutics, Inc. (the “Company”) approved the grant to each of David Smith, Francis Sarena, and Helen Collins, M.D. (each, an “Executive”) of (i) 15,000 shares of restricted common stock of the Company (each, a “Retention RSA Award”) and (ii) an option to purchase 90,000 shares of the Company’s common stock (each, a “Retention Option Award”), in each case pursuant to the Company’s 2013 Omnibus Incentive Plan.

The shares subject to each Executive’s Retention RSA Award will vest with respect to one-third of the shares subject to such Retention RSA Award on each of February 24, 2021; February 24, 2022; and February 24, 2023, in each case, subject to such Executive’s continued service with the Company on the applicable vest date. The shares subject to such Executive’s Retention Option Award will vest with respect to (i) 25% of the shares subject to such Retention Option Award on February 24, 2021; and (ii) one forty-eighth (1/48) of the shares subject to such Retention Option Award monthly commencing on March 24, 2021, in each case, subject to such Executive’s continued service with the Company on the applicable vest date.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Five Prime Therapeutics, Inc.

     

By:

 

/s/ Francis Sarena

 

Francis Sarena

 

Chief Strategy Officer and Secretary

Dated: February 26, 2020

EX-101.SCH 2 fprx-20200224.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 fprx-20200224_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 fprx-20200224_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE JSON 5 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d892673d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d892673d8k.htm" ] }, "labelLink": { "local": [ "fprx-20200224_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "fprx-20200224_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "fprx-20200224.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "fprx", "nsuri": "http://www.fiveprime.com/20200224", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d892673d8k.htm", "contextRef": "duration_2020-02-24_to_2020-02-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d892673d8k.htm", "contextRef": "duration_2020-02-24_to_2020-02-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 7 0001193125-20-050063-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-20-050063-xbrl.zip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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 d892673d8k_htm.xml IDEA: XBRL DOCUMENT 0001175505 2020-02-24 2020-02-24 false 0001175505 8-K 2020-02-24 Five Prime Therapeutics, Inc. DE 001-36070 26-0038620 111 Oyster Point Boulevard South San Francisco CA 94080 (415) 365-5600 false false false false Common Stock, par value $0.001 per share FPRX NASDAQ false XML 11 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Document and Entity Information
Feb. 24, 2020
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001175505
Document Type 8-K
Document Period End Date Feb. 24, 2020
Entity Registrant Name Five Prime Therapeutics, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-36070
Entity Tax Identification Number 26-0038620
Entity Address, Address Line One 111 Oyster Point Boulevard
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (415)
Local Phone Number 365-5600
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol FPRX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.fiveprime.com//20200224/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d892673d8k.htm fprx-20200224.xsd fprx-20200224_lab.xml fprx-20200224_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( +F 6E ?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ N8!:4"?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " "Y@%I0",2X\N\ K @ $0 &1O8U!R;W!S+V-O M&ULS9+/3L,P#(=?!>7>.NV@AZC+91,GD)"8!.(6)=X6K?FCQ*C=V].6 MK1."!^ 8^Y?/GR6W.@H=$KZD$#&1Q7PWN,YGH>.:'8FB ,CZB$[EF3.B#4G#?@D)11I& "%G$A,MD:+71"12%=\$8O^/B9NAEF-&"' M#CUEJ,H*F)PFQO/0M7 #3##"Y/)W &UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T M$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY M\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4? M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2. MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$. M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07 M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL! M_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W MF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>( M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K> M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5 MYYN MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+ MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> , M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H: M,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ M 5!+ P04 " "Y@%I0(#F&R9T" "3"P & 'AL+W=O+2?Q8>*VNI7$+2;%MV97_Y.97>U!VEDQ5SE7-&UW))E+\LHL_D><]S1VA M1[Q5O-.S<>2.-)TQ/GX M4?U+?WA[F"/3_$6*W]79E+MX'4=G?F$W85YE]Y6/!UK$T7CZ[_S.A86[G5B- MDQ2Z_XU.-VUD/5:Q6ZG9Q_"LFO[9#6_R!PTGT)% _Q.&LPQ"_> $0L<8$%*K ])4G !%K7&") M"BP!?>,)0 1)<845JK""?.))()" SVM48@WYOM$().#T!I780+YO-0()>$U2 M/$XIK.#;C6$"AI- : FLX'N.8&C =((GEU!8P;<=PP1\)WC ">P$QGU!>!F) (GGL"4YV!&P8Q 1&*!Y_"4&>Y)X)@0B)X[BG,=.;?8@P3 MN,4T\(\-,YWYMQC#!&XQQ7-/D7]V_Q8CF#QPBRF>>PHSG?NW&,-X(LFLG7+M MZ@^FKE6CHZ,TMC/K^Z>+E(;;&ULA57;;MLP#'WNOH((]K !32P[EW9#&B#+92C:M5X38,.&/2@R M$PNS)4^2T^3O1R?=,%CQ\F:)Y.'A(2D/K76PRS-E;UJI<\7[(+ BQ9S;CBY0 MD66M359$#$V"'(N50M*)7^5.-&EM7M0:#:T<#=UH MJD69HW+ 50(SY:3;PZTZ0DJMAH$;#8/*]>@^QU4'HMXE1"QB=>-$;]' ]_'* M.L.%^U&WCRE1TF%BDX#))FT*;0Y] <6CKC!H:^&=-*)EV,Z:P":RPSA MH%@4 M+7Y>0L$-;'E6(KQF'1IS* C9IMQX<4O#DZJTQ3Y?::^P>?STM9'+;"=2KC9X MCGVDRB7S!U3_/74"_@]%O4$L#!!0 ( +F M6E"ZH3F*UP$ #(& - >&POC"@J"RL.?!U[2=MH'<3*?'=G^]2=/;T0?QX(.^-#/?3+[YGTP!07 MFA:9'M23PIY49M"8TQ-E1=88O2-W- (^E2L@%RYS^LBE*)V8<[D2BF0TR0@_6L,)]$+*A<>);1Q 62Q0OR62_I/@=7KO2NDW 2F- )%9CDB M./WDG3EY!G\)D<4^3]8K;!V?DO2>[A/FP1S'A< MT0G\1[;(?:"]OXF66'$Q^&'PJ]&S_VTP",\.&C'._MAL]3T[MU9.[Z5HM8*X MEM\63&XL6&1\K4,ZX\2KYPLWI?( .$HNX%!41^2[X_8,(ZZW:6QNU9S^AYK_ M]CZWH,%Q>13MK_Z_O,M_HI@MW7-HT:L&W5!2#D*BT(O&3M0U1'GAA_GUM#P0>)S6/$HQ:#> MS@7WOT3Q U!+ P04 " "Y@%I0%FTC?T,! \ @ #P 'AL+W=O+N)!NRPH_(WD#+UW?M M*(7>>K)W=CP[.UZT)-X%>*X-F[OD.[+^1$B@9]H&V M:9U>Q49ZQ!/"+[(#3UC](9(J/Q1[+>0L9\$C!BQ1(WT7,MTU2-XBNUHCY3"> M0XAS_Y\87=-@!2M7]08L#3EZT'&Z#2UV00JK#!1RI AE:_%HB=V(M1VDF!MW MX='K>MB+.+&+6>'GR V_KB?)^.BVA@8MU&\\(##.(50;+^*1=*:W=Y-[#KO7 M^H&Q=_OJ5-*/&N/'+7\ 4$L#!!0 ( +F 6E#_P"8(O0 (4" : M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.MDD$*@S 0 +\B>4!7;>FAJ*=> MO+;]0-#5B)J$[);J[YMZ44&A!R\)8LX'LQYT4,CQT>7S%1]_276<]>@C"MA[_)1/TUP.K795]02P,$% @ MN8!:4 N/V ,A 0 5P0 !, !;0V]N=&5N=%]4>7!E&ULM51-3\,P M#/TK4Z]HS># 6V[ %>8!'\@)&X;-5^RO=']>]QN0V(J8FC;)8GS[/=>$BOS M]VT&FG3!1UH4#7-^4(I, T%3F3)$0:J$0;.$6*NL3:MK4'>SV;TR*3)$GG+/ M42SG3U#IM>?)XVZ_IUX4.F?OC&:7HMI$>T0ZW1.6"'[(H<9ENI&$8O+<"0O) MWJ(0E IU@L)Q81]+W>L&$)V%?UE+5>4,V&3604I*R@C:4@/ P9?4: 3[QNAB MO?>[TL@O.@BQZKSZD5!>SP=O/8P;&)!+*K.T!8Q)#PGPG;83UVX=\@J6$Z[];_:'29RZ!= M_,W(1TKM05\-_\GR"U!+ 0(4 Q0 ( +F 6E ?(\\#P !," + M " 0 !?D !D;V-0&UL4$L! M A0#% @ N8!:4 C$N/+O *P( !$ ( !F0$ &1O M8U!R;W!S+V-O&UL4$L! A0#% @ N8!:4)E&PO=V]R:W-H M965T&UL4$L! A0#% @ N8!:4#M^3#%A @ % 8 !0 M ( !RPL 'AL+W-H87)E9%-T&UL4$L! A0#% M @ N8!:4+JA.8K7 0 ,@8 T ( !7@X 'AL+W-T>6QE M&PO=V]R:V)O;VLN>&UL4$L! A0#% @ N8!:4/_ )@B] MA0( !H ( !T!$ 'AL+U]R96QS+W=O